
Trump Threatens 100% Tariffs on Patented Drugs Unless Firms Build U.S. Plants
Published September 26, 2025
Share this card
A satirical card depicting the dramatic ultimatum: 100% tariffs on branded drug imports unless pharmaceutical firms break ground on U.S. factories, showing collapsing foreign drugmakers and frantic domestic build efforts.
Trump announced that starting October 1, the U.S. will impose a 100% tariff on imported branded or patented pharmaceutical products, unless the companies are actively building manufacturing plants in the U.S. The exemption applies only to firms that are already “breaking ground” or “under construction.” Generic drugs aren’t included in the measure. The move is intended to force onshoring of drug production and reduce reliance on foreign pharmaceutical imports.
Read the original article →US Claims Destruct of Iranian Naval Assets at Strait
Mar 11, 2026
US Businesses Grapple with Taco Market Mayhem amid Iran Tensions
Mar 11, 2026
Trump Administration Announces Intense Strikes on Iran
Mar 10, 2026
Trump Critiques Iran's Leadership Decision, Suggests Replacement
Mar 10, 2026